Abstract
The combination of aortic regurgitation (AR) and mitral regurgitation (MR) is not uncommon in clinical practice, and varying degrees of regurgitation often result in severe hemodynamic disorders. Combined AR and MR often present a therapeutic challenge given the difficulty of attributing symptoms to 1 or both valves and the lack of reliable clinical trial data to guide clinical decision making. Transcatheter valve intervention has brought a new light to patients with high-risk valve disease. We report a patient with high-risk multiple valve disease and discuss the hemodynamic characteristics of the diagnostic process as well as therapeutic ideas.